Circulation Research Submission Guide: Requirements, Fit, and Editor Priorities

Source: 2026 JCR release, American Heart Association

Circulation Research is the basic and translational cardiovascular science journal in the AHA family. It is not where you send purely clinical outcomes work, procedural cardiology, or broad epidemiology. The journal wants to publish papers that advance understanding of cardiovascular biology at a mechanistic level.

In practice, that usually means:

• molecular cardiology

• vascular biology

• inflammation and immunology in cardiovascular disease

• cardiac metabolism

• electrophysiology mechanisms

• fibrosis, remodeling, and heart-failure biology

• translational work with a strong mechanistic backbone

The center of gravity is mechanism. A manuscript showing that a marker rises in disease is not enough. A manuscript showing how that pathway alters signaling, tissue behavior, and functional outcome in a way that sharpens cardiovascular understanding is much closer to what editors want.

This is why many otherwise strong cardiovascular papers fail here. They may be valid. They may even be important. But if they do not materially advance the biology, they fit better in a more clinical cardiology venue.

Submission caps: Regular Articles cap at 8,000 words including references with up to 8 figures and tables combined, a 300-word structured abstract, and AHA reporting requirements. Research Letters run shorter (800 words, 5 references, 1 figure or table). Supplementary video files are limited to 10 MB each in avi, mov or mpg format; larger videos go in a zip file.

• Submission: AHA online submission system upload. The AHA journal page portal accepts the package (manuscript or a single PDF with figures and tables, supplemental files, author details, a data availability statement in the Methods, suggested reviewers and exclusions, and a clinical trial registration number where relevant). Submitted manuscripts may also undergo AHA scientific integrity assessments, including analytical tools that use AI.

• Editorial screen: first editor read. The editors decide whether to refer the manuscript for external peer review, and manuscripts not likely to receive a priority sufficient for publication are returned after initial screening. The editor evaluates mechanistic depth (not just association), causal cardiovascular biology, single-model vs. multi-model evidence, and whether the figure sequence closes the causal loop. The AHA does not publish a desk-rejection rate.

• Peer review. Reviewers are matched to the paper's subfield, and authors are encouraged to suggest at least five potential reviewers. The AHA publishes no reviewer count and no reviewer turnaround time. Manuscripts that receive an initial favorable response undergo independent statistical review when appropriate.

• First editorial decision. The journal says a decision is communicated by email and typically made in fewer than 21 days for Regular Articles. Revision is a common outcome for papers that pass the editorial screen.

• Revision rounds and publication. Authors have 90 days from the decision letter to return a revision of a Regular Article (30 days for a Research Letter). All Original Research articles are published Online First within 24 hours of acceptance.

Source: American Heart Association, Circulation Research author guidelines

Do not try to rescue a thin paper by labeling it a different format. Editors will still assess whether the science looks finished, and a research letter that reads like an incomplete full paper is a recognizable pattern.

Before submitting to Circulation Research, a Circulation Research manuscript fit check identifies whether the package meets the editorial bar before you commit to the submission.

The first pass is usually not about line-by-line methods. It is about editorial fit and consequence.

The framing should help the editor see three things quickly:

• what biological problem the paper addresses

• what the manuscript explains mechanistically

• why that explanation matters to cardiovascular science now

That is a different framing from a general cardiology journal. You are not trying to sell immediate practice change. You are trying to show that the paper materially improves understanding of cardiovascular biology.

The easiest way to check that is to read only:

• title

• abstract

• first figure

• first paragraph of the discussion

If the mechanism still feels vague after that, the paper is not ready for this venue.

Your cover letter should not waste space flattering the journal. It should do four jobs.

Across cardiovascular manuscripts targeting Circulation Research, three desk-screen patterns recur because the journal is not a general cardiology outlet and not a descriptive translational-science venue. (Per AHA Circulation Research guidance and the journal's recent publication pattern, the paper has to read as causal cardiovascular biology: the abstract, first figure, methods, validation sample, controls, supplementary files, references, and cover letter all need to make the mechanism visible before the upload reaches the handling editor.) The patterns below are testable against your own manuscript before you commit the AHA journal page upload.

Descriptive cardiovascular association without causal mechanistic closure

Across cardiovascular manuscripts targeting Circulation Research, the most consistent failure mode is a paper whose disease association, omics signature, imaging readout, or phenotype is real but whose figure sequence still stops before mechanism. Circulation Research editors can usually see the gap in the abstract, Figure 1, methods, controls, and supplementary validation files.

The manuscript may show that a pathway, cell state, metabolite, transcript, electrophysiology feature, vascular phenotype, inflammatory program, or remodeling marker changes in disease, but it does not prove how that change drives the cardiovascular process.

Common component-level problems include a first figure that establishes association rather than causal direction, methods that rely on one perturbation without rescue, controls that rule out only the easiest alternative explanation, supplementary figures that bury the one mechanistic experiment, references that support plausibility rather than causality, and a cover letter that says "mechanistic insight" without naming the mechanism the paper actually establishes.

The fix is not cosmetic. The strongest Circulation Research-ready revision adds the decisive perturbation, rescue, knockout, dose-response, human-sample validation, orthogonal assay, or functional readout that connects molecular change to cardiovascular consequence.

If the paper remains primarily clinical association, biomarker discovery, or descriptive multi-omics after that check, the better redirect set is Circulation, JACC, European Heart Journal, Cardiovascular Research, Basic Research in Cardiology, or a specialty cardiovascular biology venue rather than Circulation Research.

Check descriptive cardiovascular association without causal mechanistic closure before submitting to Circulation Research →

Single-model evidence stretched into a broad cardiovascular claim

For manuscripts targeting Circulation Research, the second recurring pattern is an evidence package whose central claim depends too heavily on one model system.

The figure may be attractive, the methods may be competent, and the biology may be plausible, but the manuscript asks Circulation Research to accept a field-level cardiovascular conclusion from one mouse strain, one induced pluripotent stem cell line, one cell culture condition, one inhibitor, one sex, one time point, or one assay family.

At this tier, the abstract and cover letter need to explain why the mechanism generalizes across the relevant cardiovascular context. Editors and reviewers look for named manuscript components that de-risk overreach: independent validation cohorts, sex-aware analyses where relevant, in vivo and ex vivo agreement, multiple perturbation directions, rescue experiments, blinded quantification, hemodynamic or electrophysiology confirmation, and supplementary sensitivity tests.

When those components are missing, the discussion often overcompensates by promising therapeutic translation that the current figures cannot support. A realistic fix is to lower the claim, add orthogonal validation, or redirect.

Papers that remain narrow but solid may fit Cardiovascular Research, JACC: Basic to Translational Science, Basic Research in Cardiology, American Journal of Physiology Heart and Circulatory Physiology, Arteriosclerosis, Thrombosis, and Vascular Biology, or Journal of Molecular and Cellular Cardiology. A Circulation Research submission should make the model breadth proportionate to the claim before upload, not after reviewer request.

Check single model evidence stretched into a broad cardiovascular claim before submitting to Circulation Research →

Translational or clinical framing that outruns basic cardiovascular evidence

Across Circulation Research-targeted manuscripts, the third pattern is a strong preclinical or patient-linked story framed as if it already supports a therapeutic, diagnostic, or practice-changing conclusion. Circulation Research can publish translationally meaningful work, but the title, abstract, methods, limitations, references, and cover letter still need to place the basic cardiovascular mechanism first.

The problem appears when the cover letter foregrounds future treatment, risk stratification, or clinical adoption while the figures mostly establish pathway behavior in a limited experimental setting. Reviewers then read the manuscript as overclaiming, even when the underlying biology is promising.

The manuscript components to audit are concrete: does the abstract name the mechanistic question before the translational promise; does the methods section include controls that separate mechanism from correlation; do the figures show functional consequence rather than only expression change; do the supplementary tables document sample inclusion, exclusion, and validation logic; do references compare against recent Circulation Research and Cardiovascular Research papers rather than broad clinical cardiology citations;

does the cover letter explain why Circulation Research is the right home instead of Circulation, JACC, European Heart Journal, JACC: Basic to Translational Science, Cardiovascular Research, or Nature Cardiovascular Research.

The fix is usually to right-size the claim: lead with the cardiovascular biology the manuscript proves now, state the translational implication as bounded, and keep limitations explicit. That posture reads stronger to Circulation Research editors than a clinical promise that the current package cannot yet defend.

Check whether your Circulation Research manuscript is submission-ready

Check translational or clinical framing that outruns basic cardiovascular evidence before submitting to Circulation Research →

For Circulation Research-targeted manuscripts, three patterns consistently predict desk-screen failure at Circulation Research (American Heart Association).

Scope-fit ambiguity in the abstract. Circulation Research editors move fastest on manuscripts whose contribution is obviously aligned with cardiovascular basic-science research with mechanistic depth and translational implications. The named failure pattern: mechanism-only cardiovascular papers without translational-implication framing extend revision rounds. Check whether your abstract reads to Circulation Research's scope

Methods package incomplete for the journal's reviewer pool. Circulation Research reviewers expect specific methodological detail. Preliminary mechanistic claims without in-vivo validation extend reviewer consultation. Check if your methods package is reviewer-complete

Reference-list and clean-citation failure mode. The AHA submission guidelines say references to retracted or potentially problematic sources without proper context should be avoided. Check whether your reference list is clean against Crossref + Retraction Watch

Editorial evidence signal for Circulation Research (American Heart Association). Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Circulation research reviewers expect both mechanistic depth and translational-implication framing; mechanism-only papers without translational pathway extend revision. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.